3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
5
Neoplasm Metastasis
1
Metastatic Castration-resistant Prostate Cancer
1
Biochemical Recurrent Prostate Cancer
1
Interventions
olaparib
4
Abiraterone Acetate
3
Pluvicto
2
rucaparib
1
radium Ra 223 dichloride
1
enzalutamide
1
enfortumab vedotin
1
copanlisib
1
cabazitaxel
1
abiraterone
1
Radium-223
1
Prednisone
1
Prednisolone
1
Nivolumab
1
Androgen Antagonists
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Metastatic Castration-resistant Prostate Cancer
×
Radium-223
×
Clear all
NCT04109729
2026-06-01
Rad2Nivo
University of Utah
Phase 1
Active not recruiting
39 enrolled